Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 1 Study of Carboplatin and Gemcitabine Chemotherapy and Stereotactic Body Radiosurgery for the Palliative Treatment of Persistent or Recurrent Gynecologic Cancer

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT01652794
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:35:51.881282+00:00
Published At
2015-08-04T00:00:00+00:00
Record Updated At
2015-08-04
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Leydig Cell Tumor", "Ovarian Sarcoma", "Ovarian Stromal Cancer", "Pseudomyxoma Peritonei", "Recurrent Cervical Cancer", "Recurrent Endometrial Carcinoma", "Recurrent Fallopian Tube Cancer", "Recurrent Ovarian Epithelial Cancer", "Recurrent Ovarian Germ Cell Tumor", "Recurrent Primary Peritoneal Cavity Cancer", "Recurrent Uterine Sarcoma", "Recurrent Vaginal Cancer", "Recurrent Vulvar Cancer"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2015-08-04"
protocolSection.identificationModule.nctId
"NCT01652794"
protocolSection.identificationModule.officialTitle
"A Phase 1 Study of Carboplatin and Gemcitabine Chemotherapy and Stereotactic Body Radiosurgery for the Palliative Treatment of Persistent or Recurrent Gynecologic Cancer"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Leydig Cell Tumor (protocolSection.conditionsModule.conditions)
  • Ovarian Sarcoma (protocolSection.conditionsModule.conditions)
  • Ovarian Stromal Cancer (protocolSection.conditionsModule.conditions)
  • Pseudomyxoma Peritonei (protocolSection.conditionsModule.conditions)
  • Recurrent Cervical Cancer (protocolSection.conditionsModule.conditions)
  • Recurrent Endometrial Carcinoma (protocolSection.conditionsModule.conditions)
  • Recurrent Fallopian Tube Cancer (protocolSection.conditionsModule.conditions)
  • Recurrent Ovarian Epithelial Cancer (protocolSection.conditionsModule.conditions)
  • Recurrent Ovarian Germ Cell Tumor (protocolSection.conditionsModule.conditions)
  • Recurrent Primary Peritoneal Cavity Cancer (protocolSection.conditionsModule.conditions)
  • Recurrent Uterine Sarcoma (protocolSection.conditionsModule.conditions)
  • Recurrent Vaginal Cancer (protocolSection.conditionsModule.conditions)
  • Recurrent Vulvar Cancer (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.